The Lancet Neurology in conversation with
174 episodes - English - Latest episode: about 1 month ago -Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
March 14, 2024 23:00 - 25 minutes - 17.4 MBJaimie Steinmetz and Theo Vos from the Institute for Health Metrics and Evaluation, and Katrin Seeher and Tarun Dua from WHO, join Heather Brown and Lauren Southwell to discuss new data on the global, regional, and national burden of disorders affecting the nervous system. The Article is published in the April issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thel...
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
February 14, 2024 23:00 - 12 minutes - 8.49 MBGiovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Personal View is published in the March issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/S1474-4422(23)00447-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.co...
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
January 22, 2024 23:00 - 21 minutes - 15 MBMarianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00414-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.c...
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
December 13, 2023 23:00 - 18 minutes - 12.7 MBCecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in the January issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00358-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... https:/...
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
November 15, 2023 23:00 - 24 minutes - 16.6 MBRustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology, of the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00315-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... http...
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations
October 20, 2023 09:00 - 26 minutes - 18.3 MBNjideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architecture of Parkinson's disease in these underserved populations. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00283-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today...
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
September 20, 2023 22:00 - 14 minutes - 10.1 MBAnthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljourna...
William Jagust on amyloid β and cognition
August 16, 2023 22:00 - 13 minutes - 9.37 MBWilliam Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on this topic is published in the September issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00128-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation...
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
July 19, 2023 22:00 - 14 minutes - 10 MBStephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00215-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... https://twitter.c...
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
June 21, 2023 22:00 - 17 minutes - 11.9 MBBenzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blott to discuss palliative care for individuals with neurological diseases, exploring the challenges and opportunities in enhancing the quality of life for those affected by neurological conditions. Their Review is published in the July issue of The Lance...
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
May 18, 2023 22:00 - 18 minutes - 12.8 MBAndrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue of The Lancet Neurology. Read the full article here: thelancet.com/journals/laneur/article/PIIS1474-4422(23)00031-5/fulltext?dgcid=buzzsprout_icw_podcast_laneur Continue this conversation on social! Follow us today at... https://twitter.com/thelancet ...
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
April 13, 2023 10:00 - 15 minutes - 10.6 MBKaren Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lancet Neurology. Read the Personal View here: Chronic effects of inflammation on tauopathies Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedica...
Kerstin Hellwig on family planning considerations in MS
March 15, 2023 23:00 - 14 minutes - 9.93 MBKerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Geraldine Dawson on advances in the prediction of autism during infancy
February 16, 2023 11:00 - 24 minutes - 16.9 MBGeraldine Dawson (Duke University School of Medicine, NC, USA ) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology. Read the full article: Prediction of autism in infants: progress and challenges Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn...
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
January 19, 2023 23:00 - 8 minutes - 6.05 MBEllisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology. Read the full article: Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST) Continue this con...
Beau Ances on amyloid biomarkers in Alzheimer’s
December 12, 2022 23:00 - 11 minutes - 7.98 MBBeau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology. Read the full article: Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https:/...
Axel Petzold on the diagnosis and classification of optic neuritis
November 16, 2022 23:00 - 20 minutes - 13.8 MBAxel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet Neurology, which sets out new criteria for the diagnosis and classification of optic neuritis. Read the Position Paper: Diagnosis and classification of optic neuritis Continue this conversation on social! Follow us today at... https://twitter.com/thel...
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
October 18, 2022 22:00 - 14 minutes - 10.1 MBMaeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers on intraoperative electrocorticography, and describes some of the challenges of this technique and what the future steps are for the field; the Article is published in the November issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https:/...
Jerome Siegel on sleep habits
September 14, 2022 22:00 - 43 minutes - 30.1 MBJerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the sleep habits of various species; his Review is published in the October issue of The Lancet Neurology, which is the fourth paper in The Lancet’s Series on sleep and sleep disorders. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedic...
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
August 10, 2022 22:00 - 17 minutes - 11.9 MBLaurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology. Read the full Review: Emerging therapies for Duchenne muscular dystrophy Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet ...
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
July 13, 2022 22:00 - 22 minutes - 15.8 MBAndreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology. Read the full article: The Boston criteria version 2.0 for cerebral amyloid angiopathy Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://faceb...
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
June 15, 2022 22:00 - 18 minutes - 13 MBSarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying therapies. Continue this conversation on social! Follow us today at... https://twitter.com/thelanc...
Mark Hallett on functional neurological disorder
May 13, 2022 15:00 - 8 minutes - 6.03 MBMark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important. Read the full article: Functional neurological disorder: new subtypes and shared mechanisms Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://...
Eva Feldman on advances in understanding ALS
April 13, 2022 22:00 - 22 minutes - 15.6 MBEva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-la...
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's
April 06, 2022 13:00 - 27 minutes - 18.7 MBEstrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet...
John Collinge on a treatment for CJD
March 16, 2022 23:00 - 14 minutes - 10.2 MBJohn Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-la...
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
February 22, 2022 10:00 - 7 minutes - 5.48 MBAlexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology. Read the full article: Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com...
Giuseppe Citerio on frailty and TBI
January 19, 2022 23:00 - 9 minutes - 6.61 MBGiuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtub...
Alberto Costa on memantine in adolescents and young adults with Down syndrome
December 20, 2021 23:00 - 15 minutes - 10.5 MBAlberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00369-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetm...
Olivier Rascol on amantadine for patients with movement disorders
November 17, 2021 23:00 - 28 minutes - 19.6 MBOlivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00249-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljou...
Antonio Uccelli on stems cells for MS
October 20, 2021 22:00 - 18 minutes - 12.5 MBAntonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesenchymal stem cells for multiple sclerosis. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00301-X/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/co...
Priya Palta on blood pressure control and cognitive decline
September 15, 2021 22:00 - 16 minutes - 11.6 MBPriya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology, provides an update of the mounting evidence that links hypertension with dementia risk. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00248-9/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https:/...
Adam Boxer on tau biomarkers
August 18, 2021 22:00 - 12 minutes - 8.42 MBAdam Boxer (University of California, San Francisco) discusses his research, published in August issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00214-3/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://link...
Irene Cortese on the difficulties of designing clinical trials
July 21, 2021 22:00 - 9 minutes - 6.87 MBIrene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy and talks about a pilot study of virus-specific T cells for treatment of this population, published in the August issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00174-5/fulltext Continue this conversation on social! Follow us today at... https://...
Doug Turnbull on mitochondrial diseases in adults
June 16, 2021 22:00 - 20 minutes - 13.9 MBDoug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and explains how important these diseases are for neurologists. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00098-3/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https...
Geert Jan Biessels on predicting post-stroke cognitive impairment
May 19, 2021 22:00 - 7 minutes - 5.52 MBGeert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in our June issue, on using strategic infarct locations to predict post-stroke cognitive impairment. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00060-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp...
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
April 21, 2021 22:00 - 8 minutes - 5.94 MBHenk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00042-9/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Anne MacGregor on menstrual migraine
March 17, 2021 23:00 - 12 minutes - 8.85 MBAnne MacGregor discusses her recent Review of menstrual migraine, and explains why the problem needs greater recognition. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30482-8/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Peter Rothwell on asymptomatic carotid stenosis and stroke
February 17, 2021 23:00 - 9 minutes - 6.51 MBPeter Rothwell (Oxford University) discusses his research, found in our new issue, on asymptomatic carotid stenosis and stroke. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30484-1/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Spinal cord injury and degenerative cervical myelopathy
January 20, 2021 23:00 - 19 minutes - 13.5 MBProfessor Michael Fehlings discusses the implications of his two papers in the Jan 2021 issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30407-5/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Genetic risk factors for sCJD
December 22, 2020 17:00 - 23 minutes - 15.9 MBEmma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Prednisone in short-term prevention of cluster headache
November 24, 2020 23:00 - 9 minutes - 6.32 MBMark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
PET imaging of inflammation in neurological and psychiatric disorders
October 21, 2020 22:00 - 9 minutes - 6.34 MBRobert Innis discusses his work on measuring neuroinflammation using PET imaging. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Neurological associations of COVID-19
September 04, 2020 23:00 - 11 minutes - 7.87 MBTom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Advances in understanding of Rett syndrome
July 31, 2020 06:30 - 20 minutes - 14.3 MBHuda Zoghbi discusses the prospects for future therapies in Rett syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Management of Parkinson's disease
June 17, 2020 15:00 - 10 minutes - 7.4 MBBas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Optimal time to treat Huntington's Disease
May 26, 2020 15:00 - 12 minutes - 8.9 MBSarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Evidence-based support for autistic people across the lifespan
April 28, 2020 15:00 - 21 minutes - 14.6 MBMeng-Chuan Lai discusses the current evidence base for supporting autistic people. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Oral immunomodulating therapies in relapsing MS
March 19, 2020 08:00 - 11 minutes - 7.93 MBTobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The global burden of neurological conditions
November 06, 2019 08:00 - 37 minutes - 25.6 MBAndrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv